Effects of Hormone Replacement Therapy on Insulin Resistance and Platelet Function Tests
dc.contributor.author | Sarac, Fulden | |
dc.contributor.author | Saydam, Güray | |
dc.contributor.author | Sahin, Fahri | |
dc.contributor.author | Oztekin, Kemal | |
dc.contributor.author | Saygili, Fusun | |
dc.contributor.author | Tuzun, Mehmet | |
dc.contributor.author | Yilmaz, Candeger | |
dc.date.accessioned | 2019-10-27T20:21:23Z | |
dc.date.available | 2019-10-27T20:21:23Z | |
dc.date.issued | 2009 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objectives: The aim of this study was to evaluate measures of insulin resistance and platelet function in postmenopausal women with oral or transdermal hormone replacement therapy (HRT). Subjects and Methods: Eighty women divided into four groups of 20 each were enrolled in the study. Group 1: postmenopausal hysterectomized women who received only transdermal estradiol (13.9 mg/12.5 cm(2)); group 2: women with intact uterus who were treated with estrogen-progestin combination ( HRT); group 3: postmenopausal women who were treated with the selective estrogen receptor modulator tibolone, and group 4: women who were not taking any drugs for HRT were chosen as a control group ( group 4). Results: In group 2, homeostasis model assessment of insulin resistance and fasting insulin levels were 2.90 +/- 0.37 and 9.3 +/- 3.0 mu U/ml, respectively, prior to administration of HRT. These levels were reduced to 1.91 +/- 0.41 (p = 0.001) and 7.1 +/- 2.7 mu U/ml (p = 0.002), respectively, after drug therapy. Mean levels of high-sensitivity C-reactive protein (hsCRP) were decreased with HRT only in group 2 (p = 0.002). No changes for biochemical and hematological parameters were observed in the other groups. Platelet function tests showed no differences after HRT in any group. Conclusions: Estrogen-progestin combination HRT decreased measures of insulin resistance and hsCRP levels, but had no effect on platelet function tests in postmenopausal women. Copyright (C) 2008 S. Karger AG, Basel | en_US |
dc.identifier.doi | 10.1159/000163045 | en_US |
dc.identifier.endpage | 47 | en_US |
dc.identifier.issn | 1011-7571 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 19060490 | en_US |
dc.identifier.startpage | 43 | en_US |
dc.identifier.uri | https://doi.org/10.1159/000163045 | |
dc.identifier.uri | https://hdl.handle.net/11454/41754 | |
dc.identifier.volume | 18 | en_US |
dc.identifier.wos | WOS:000261385800008 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.relation.ispartof | Medical Principles and Practice | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Insulin resistance | en_US |
dc.subject | Platelet function | en_US |
dc.subject | Hormone replacement | en_US |
dc.subject | Postmenopausal women | en_US |
dc.title | Effects of Hormone Replacement Therapy on Insulin Resistance and Platelet Function Tests | en_US |
dc.type | Article | en_US |